Do low muscle mass and low androgen tone increase insulin resistance and make weight loss harder?

The relationship between muscle mass, hormonal status, and metabolic health is foundational to weight management, particularly in the postmenopausal transition. However, the specific influence of androgens on insulin sensitivity is highly dependent on biological sex.

Clinical effectiveness and insulin resistance

Skeletal muscle is the body’s primary site for insulin-stimulated glucose disposal, accounting for 80–90% of peripheral glucose uptake.

• Muscle mass and glucose: A reduction in skeletal muscle mass directly diminishes the total capacity for glucose clearance. Clinical data using the hyperinsulinemic-euglycemic clamp show that higher muscle mass correlates with superior insulin sensitivity.
• Sarcopenia risks: In older populations, sarcopenia (loss of muscle) is mechanistically linked to reduced GLUT4 expression—the primary glucose transporter—and mitochondrial dysfunction, significantly increasing the risk of type 2 diabetes.
• The androgen paradox: In females, the claim that low androgen tone causes insulin resistance is unsupported. Research consistently shows that androgen excess (e.g., in PCOS) is the primary driver of insulin resistance in women. High endogenous testosterone levels in postmenopausal women are predictive of metabolic syndrome, while lower androgen tone is generally associated with better insulin sensitivity.

Mechanistic explanations for weight loss resistance

While low androgens do not drive insulin resistance in women, the combination of low muscle mass and hormonal shifts significantly complicates weight loss.

• Metabolic rate: Skeletal muscle is a major determinant of resting energy expenditure (REE). Lower muscle mass results in a reduced basal metabolic rate, requiring a much lower caloric intake to achieve a deficit.
• Metabolic adaptation: During weight loss, individuals with low muscle mass often experience "metabolic adaptation," where REE drops disproportionately to the weight lost. This often leads to weight loss plateaus and a higher risk of regain.
• Anabolic signaling: Androgens are necessary for maintaining muscle mass. While excess androgens are metabolically harmful for women, a baseline anabolic tone is required to prevent muscle wasting, which indirectly supports the metabolic "floor" for weight management.

Bottom line

While lower skeletal muscle mass is a confirmed driver of insulin resistance and weight loss difficulty, the role of androgens in women is the opposite of the claim: lower androgen levels are generally protective against insulin resistance, whereas androgen excess impairs glucose metabolism. Maintaining muscle mass remains the most critical factor for supporting glucose uptake and metabolic rate.